Interestingly, in patients with Alzheimer’s disease, significantly decreased LPS-induced release of IL-6 and IL-1β in PBMC after six months of omega-3 supplementation (2.3 g/day) was reported [25]. This evidence concerns the gene IL1B and early-onset autosomal dominant Alzheimer disease.